기자가 쓴 기사 더보기

[편집자 주 - 너무 어린 아이들이 강력한 향정신성 의약품에 쉽게 노출되어 있다는 기사입니다]
At 18 months, Kyle Warren started taking a daily antipsychotic drug on the orders of a pediatrician to quell the boy's severe tempter tantrums.
Thus began a troubled toddler's journey from one doctor to another, from one diagnosis to another, involving even more drugs. Autism, bipolar disorder, hyperactivity, insomnia, oppositional defiant disorder. The boy's daily pill regimen multiplied: the antipsychotic Risperdal [리스페달], the antidepressant Prozac [프로작], two sleeping medicines and one for attention-deficit disorder. All by the time he was 3.
He was sedated, drooling and overweight from the side effects of the antipsychotic medicine. Although his mother, Brandy Warren, had been at her "wit's end" when she resorted to the drug treatment, she began to worry about Kyle's altered personality.
"All I had was a medicated little boy," Ms. Warren said. "I didn't have my son. It's like, you'd look into his eyes, and you would just see just blankness."
Today, Kyle, 6, is in his forth week of first grade, scoring high marks on his first tests. He is rambunctious and much thinner. Weaned off the drugs through a program affiliated with Tulane University in New Orleans [U.S.A.] that is aimed at helping low-income families whose children have mental health problems, Kyle now laughs easily and teases his family.
Ms. Warren and Kyle's new doctors point to his remarkable progress - and a more common diagnosis for children of attention-deficit hyperactivity disorder - as proof that he should have never been prescribed such powerful drugs in the first place.
| 인기기사 | 더보기 + |
| 1 | 메지온 '유데나필', 폰탄환자 복용 관련 미국특허 등록 |
| 2 | 넥스모스, 미국 특허청서 글루타치온 결합 DNA ‘압타민G’ 물질특허 획득 |
| 3 | "필수의료 형사리스크 완화 첫발…'개인책임→사회분담' 전환 필요성 부각" |
| 4 | '앱'도 올리브영이 최강자…성장률은 다이소, 재구매는 컬리 |
| 5 | [약업분석] 부광약품, 지난해 매출 2,000억 돌파 '완벽 턴어라운드'… 글로벌 R&D 결실 |
| 6 | 파킨슨 치료 패러다임 변화 신호…아스펜, "1년 효과 확인" |
| 7 | 3월 건정심 오르는 ‘약가제도 개편안’, 국회 서면답변으로 본 핵심 쟁점은? |
| 8 | 디티앤씨알오, 근감소증 신약개발 ‘바이오바이츠’와 비임상·임상 전주기 협력 |
| 9 | 이형훈 차관 "제약업계, 규제 대상 아닌 파트너… 약가제도 최적의 합의점 찾을 것" |
| 10 | 알고리즘이 매대 바꾼다… 디지털 경쟁 본격화 |
| 인터뷰 | 더보기 + |
| PEOPLE | 더보기 + |
| 컬쳐/클래시그널 | 더보기 + |

[편집자 주 - 너무 어린 아이들이 강력한 향정신성 의약품에 쉽게 노출되어 있다는 기사입니다]
At 18 months, Kyle Warren started taking a daily antipsychotic drug on the orders of a pediatrician to quell the boy's severe tempter tantrums.
Thus began a troubled toddler's journey from one doctor to another, from one diagnosis to another, involving even more drugs. Autism, bipolar disorder, hyperactivity, insomnia, oppositional defiant disorder. The boy's daily pill regimen multiplied: the antipsychotic Risperdal [리스페달], the antidepressant Prozac [프로작], two sleeping medicines and one for attention-deficit disorder. All by the time he was 3.
He was sedated, drooling and overweight from the side effects of the antipsychotic medicine. Although his mother, Brandy Warren, had been at her "wit's end" when she resorted to the drug treatment, she began to worry about Kyle's altered personality.
"All I had was a medicated little boy," Ms. Warren said. "I didn't have my son. It's like, you'd look into his eyes, and you would just see just blankness."
Today, Kyle, 6, is in his forth week of first grade, scoring high marks on his first tests. He is rambunctious and much thinner. Weaned off the drugs through a program affiliated with Tulane University in New Orleans [U.S.A.] that is aimed at helping low-income families whose children have mental health problems, Kyle now laughs easily and teases his family.
Ms. Warren and Kyle's new doctors point to his remarkable progress - and a more common diagnosis for children of attention-deficit hyperactivity disorder - as proof that he should have never been prescribed such powerful drugs in the first place.